We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 stocks to help you retire early

Retirement planning requires a long-term view and these three shares could bring retirement a big step closer.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

For most people, retiring early is a major goal in life. Investing in shares can help you to achieve that, but these three stocks could help you to do so a few years earlier than you expected.

AstraZeneca

AstraZeneca (LSE: AZN) has endured a challenging period due to its loss of patents on key, blockbuster drugs in recent years. This has caused a large fall in profitability, which has hurt investor sentiment to a degree. However, this weakening of investor sentiment has been more than offset by optimism towards AstraZeneca’s acquisition strategy. The company has made full use of its strong cash flow and sound finances to transform its pipeline so that it’s now all set to deliver positive growth over the medium-to-long term.

XXX

Allied to this is AstraZeneca’s income potential. It currently yields 4.1% and with dividends being covered 1.5 times, they’re very sustainable. This mix of income return plus the potential for strong growth from its new pipeline of treatments means that AstraZeneca could soar over the long run and help you retire early.

Compass

One thing that’s of great benefit to long-term investors is consistency. On this front, Compass (LSE: CPG) has huge appeal since it has an excellent track record of earnings growth. In fact, over the last five years its bottom line has increased in each year, with an annualised earnings growth rate of 8.3% during the period. This bodes well for its future returns, since it shows that it can operate in a range of economic conditions and still turn a rising profit.

The food services industry provides Compass with a relatively dependable financial outlook. That’s because demand is quite resilient and with the outlook for the UK economy being uncertain due in part to Brexit, this could cause investor sentiment towards Compass to improve. Its yield of 2.2% may be lower than the FTSE 100’s yield of 3.5%, but with dividends being covered 1.9 times by profit, there’s scope for shareholder payouts to rise by at least as much as profit over the long run.

Sainsbury’s

Although the UK retail sector faces an uncertain future, Sainsbury’s (LSE: SBRY) has the right strategy to perform well. Its pricing is simple and focuses on offering value for money rather than chasing low prices, while its acquisition of Argos owner Home Retail provides growth potential. The synergies between the two companies are significant and there are major cross-selling opportunities that could boost Sainsbury’s bottom line over the medium-to-long term.

Sainsbury’s yields 4.4% at the present time and its dividends are covered twice by profit. While dividend growth may be somewhat low in the near term due to the uncertain operating environment it faces, Sainsbury’s has significant headroom when making dividend payments and this could lead to a rapidly rising income return over the coming years. Therefore, it offers excellent total return potential and alongside Compass and AstraZeneca, could help you retire early.

Peter Stephens owns shares of AstraZeneca and Sainsbury (J). The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »